Skip to main content
Figure 5 | BMC Infectious Diseases

Figure 5

From: Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection

Figure 5

Most important factors encouraging HCV treatment completion by subgroup. ** The treatment mentioned in subgroup descriptions refers to treatment with pegylated interferon and ribavirin (PR). **Difference between groups is statistically significant at p ≤ 0.05.Sample sizes may vary for individual factors because of missed questions or participant non-response.

Back to article page